Klebsiella pneumoniae – a key driver in the global spread of antimicrobial resistance and a target for new approaches in diagnostics, surveillance and alternative therapeutics (KLEB-GAP).
- Sundsfjord, Arnfinn (Primary Chief Investigator (PCI))
- Hoyland Lohr, Iren (Chief Investigator (CI))
- Samuelsen, Orjan (Chief Investigator (CI))
- Sunde, Marianne (Chief Investigator (CI))
- Lunestad, Bjorn Tore (Chief Investigator (CI))
- Brisse, Sylvain (Chief Investigator (CI))
- Giske, Christian Georg (Chief Investigator (CI))
- Bengoechea, Jose (Chief Investigator (CI))
- Holt, Kathryn (Chief Investigator (CI))
- Frantzen, Cyril (Chief Investigator (CI))
- Wyres, Kelly (Chief Investigator (CI))
- Universitetet i Tromsø (University of Tromsø - The Arctic University of Norway)
- Stavanger University Hospital
- University Hospital of North Norway
- Norwegian Veterinary Institute
- Institute of Marine Research
- Institut Pasteur (Pasteur Institute)
- Karolinska Universitetssjukhuset (Karolinska University Hospital)
- Queen's University Belfast
- ACD Pharma
Project: Research